The medical director and quality requirements in the dialysis facility.
Four decades after the successful implementation of the ESRD program currently providing life-saving dialysis therapy to >430,000 patients, the definitions of and demands for a high-quality program have evolved and increased at the same time. Through substantial technological advances ESRD care improved, with a predominant focus on the technical aspects of care and the introduction of medications such as erythropoiesis-stimulating agents and active vitamin D for anemia and bone disease management. Despite many advances, the size of the program and the increasingly older and multimorbid patient population have contributed to continuing challenges for providing consistently high-quality care. Medicare's Final Rule of the Conditions for Coverage (April 2008) define the medical director of the dialysis center as the leader of the interdisciplinary team and the person ultimately accountable for quality, safety, and care provided in the center. Knowledge and active leadership with a hands-on approach in the quality assessment and performance improvement process (QAPI) is essential for the achievement of high-quality outcomes in dialysis centers. A collaborative approach between the dialysis provider and medical director is required to optimize outcomes and deliver evidence-based quality care. In 2011 the Centers for Medicare & Medicaid Services introduced a pay-for-performance program-the ESRD quality incentive program (QIP)- with yearly varying quality metrics that result in payment reductions in subsequent years when targets are not achieved during the performance period. Success with the QIP requires a clear understanding of the structure, metrics, and scoring methods. Information on achievement and nonachievement is publicly available, both in facilities (through the facility performance score card) and on public websites (including Medicare's Dialysis Facility Compare). By assuming the leadership role in the quality program of dialysis facilities, the medical director is given an important opportunity to improve patients' lives and effect true change in a patient population dealing with a very challenging chronic disease. This article in the series on the role of the medical director summarizes the medical director's specific role in the quality improvement process in the dialysis facility and the associated requirements and programs, including QAPI and QIP.
Satellite Healthcare, San Jose, California, and Department of Medicine, Division of Nephrology, Stanford University, Palo Alto, California.
Brigitte
B
Schiller
D000554:Ambulatory Care Facilities / Q000331:legislation & jurisprudence / Q000458:organization & administration / Q000592:standards*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D007857:Leadership; D008484:Medicaid; D006278:Medicare; D010348:Patient Care Team / Q000458:organization & administration; D008486:Physician Executives / Q000458:organization & administration*; D010819:Physician's Role; D011785:Quality Assurance, Health Care; D058996:Quality Improvement; D019984:Quality Indicators, Health Care; D011787:Quality of Health Care; D006435:Renal Dialysis; D014481:United States
Medical Director; QAPI; QIP; dialysis; quality improvement